Marksans Pharma Limited

NSE: MARKSANS BSE: 524404 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

257 2(1%)

Near 52W High of 271

Volume

9L as on 24, Dec

Open

294

High

300

Low

293

255

VWAP

295

52 Week High

271

52 Week Low

155

Viand Research Rating

Quality Score

00/00

Growth Score

00/00

Valuation Score

00/00

Momentum Score

00/00

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

11,639

No. of Shares

45.3

P/E

99.07

P/B

11.79

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

11.89

ROCE

Profit Growth

Listing Date

21-Jan-02

Promoter Holding

43.87%

FII Holding

8.13%

DII Holding

5.91%

Price Chart

Price Performance

1 Week10%

1 Month5%

3 Months2%

6 Months2%

1 Year2%

YTD2%

Moving Average

5 Day SMA306

10 Day SMA311

20 Day SMA326

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	311	297	307	310
Resistance 2	307	296	303	306
Resistance 1	300	295	300	299
Pivot Point	296	294	296	296
Support 1	290	293	292	288
Support 2	286	292	290	285
Support 3	279	291	286	278

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	Div Yld %
1	SUNPHARMA	4,42,187	1843	2%	14%	2%	9%	39	0	0	0
2	DIVISLAB	1,80,280	6791	2%	6%	4%	1%	65	0	0	0
3	TORNTPHARM	1,53,281	4529	0%	8%	18%	40%	64	0	0	0
4	APOLLOHOSP	1,19,047	8280	3%	7%	12%	17%	58	0	0	0
5	CIPLA	1,14,869	1422	1%	10%	7%	4%	22	0	0	0
6	DRREDDY	1,11,015	1330	0%	1%	7%	7%	20	0	0	0
7	ZYDUSLIFE	1,09,378	1087	6%	16%	15%	17%	20	0	0	0
8	LUPIN	1,04,017	2275	1%	2%	9%	15%	23	0	0	0
9	MANKIND	1,00,482	2434	3%	7%	7%	2%	49	0	0	0
10	MAXHEALTH	96,867	995	7%	1%	15%	14%	0	0	0	0
Load More

Shareholding Pattern (%)

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.85%	(0.01) 43.85%	(0.01) 43.85%	(0.01) 43.85%	(-5.21) 43.85%	(0.41) 49.00%	(0.41) 48.60%	(0.01) 48.25%	(0.01) 48.25%	(0.01) 48.25%	(0.01) 48.25%
FIIs	(-8.81) 8.13%	(-3.01) 16.92%	(-2.31) 19.89%	(0.21) 22.19%	(0.61) 21.95%	(2.71) 21.31%	(3.01) 18.59%	(0.01) 15.57%	(0.51) 15.55%	(0.21) 15.07%	(-0.21) 14.90%	(10.91) 15.11%	(0.21) 4.23%	(0.01) 4.06%	(0.61) 4.04%	(0.91) 3.46%	(-0.11) 2.59%	(0.01) 2.64%
DIIs	(0.61) 5.91%	(-0.21) 5.28%	(1.01) 5.50%	(0.31) 4.55%	(0.21) 4.30%	(0.41) 4.10%	(-1.41) 3.75%	(0.41) 5.17%	(0.71) 4.76%	(0.41) 4.02%	(2.21) 3.65%	(0.51) 1.46%	(0.01) 0.96%	(0.01) 0.95%	(0.51) 0.94%	(0.11) 0.47%	(-0.11) 0.41%	(0.01) 0.53%
Public	42.08%	33.93%	30.74%	29.37%	29.88%	30.70%	33.77%	35.40%	35.81%	37.06%	37.60%	39.57%	45.79%	46.38%	46.77%	47.82%	48.75%	48.58%
No. of Shareholders	255,153	265,788	256,221	257,273	259,813	248,845	235,500	254,699	237,377	207,937	188,447	198,382	213,123	217,743	221,359	220,090	214,998	201,451

Quarterly Results

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	754	720	620	708	682	642	591	560	586	531	500	486	480	453	434	418	363	361	349
Expenses	594	576	520	582	543	495	462	450	453	417	398	376	403	372	361	354	305	301	272
Operating Profit	161	144	100	127	139	147	128	110	133	114	102	110	77	80	73	64	58	60	77
OPM %	21	20	16	18	20	23	22	20	23	21	20	23	16	18	17	15	16	17	22
Other Income	20	22	6	15	28	0	15	17	5	19	10	11	18	14	16	15	12	9	6
Interest	6	6	6	3	3	3	3	5	3	2	2	2	2	3	2	5	1	2	1
Depreciation	24	27	23	23	21	20	20	21	22	18	14	14	13	14	11	21	9	7	7
Profit before tax	151	133	77	116	143	125	120	100	113	114	97	104	79	78	76	53	60	60	75
Tax %	25	26	24	22	27	22	26	23	26	26	27	21	21	23	21	44	20	23	16
Net Profit	114	99	58	91	105	98	89	78	83	84	70	83	62	60	60	30	48	46	63
EPS in Rs	2.5	2.17	1.29	2	2.31	2.13	1.96	1.73	1.84	1.84	1.52	1.81	1.57	1.51	1.46	0.69	1.18	1.11	1.53

Profit and Loss

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	2623	2177	1852	1491	1376	1134	1000	913	767	893	797	630	438
Expenses	2094	1719	1513	1232	1037	942	868	834	722	757	612	512	369
Operating Profit	529	459	340	259	340	192	132	78	45	136	185	118	69
OPM %	20	21	18	17	25	17	13	9	6	15	23	19	16
Other Income	70	50	59	42	7	0	5	8	7	9	3	4	4
Interest	12	11	9	8	8	9	10	10	7	10	16	19	15
Depreciation	83	74	52	45	36	27	23	27	30	28	16	16	16
Profit before tax	504	424	338	248	302	157	104	50	15	107	156	86	44
Tax %	24	26	21	25	21	23	23	28	24	23	28	15	-12
Net Profit	383	315	265	187	239	121	80	36	11	83	112	74	49
EPS in Rs	8.4	6.92	5.88	4.51	5.76	2.95	1.87	0.8	0.22	1.92	2.67	1.87	1.19
Dividend Payout %	10	9	9	6	4	3	3	6	23	21	4	5	10

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	207	230	237	99	179	233	27	50	14	31	155	65	39
Cash from Investing Activity	-49	-141	-259	-84	-45	-60	-13	-39	-21	-123	-33	-4	-5
Cash from Financing Activity	-65	-69	198	80	-15	-114	-21	3	-3	-58	17	-29	-40
Net Cash Flow	93	21	176	94	118	60	-7	15	-10	-150	138	31	-7

Balance Sheet

	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	45	45	45	45	45	41	41	41	41	41	41	41	41	39	39
Reserves	2643	2422	2236	2020	1700	1161	846	595	502	430	392	401	326	90	34
Borrowings	332	322	198	244	123	111	34	30	100	118	110	100	101	173	176
Other Liabilities	422	451	432	372	322	323	307	236	160	142	209	180	207	188	152
Total Liabilities	3442	3240	2911	2681	2190	1636	1228	902	802	731	752	722	676	490	401
Fixed Assets	1054	982	787	776	486	428	309	303	270	279	267	270	166	146	156
CWIP	7	27	11	9	10	3	12	0	0	0	0	0	0	0	0
Investments	1	1	15	27	1	0	0	0	0	0	0	0	0	0	0
Other Assets	2381	2230	2098	1869	1694	1205	907	599	533	451	484	452	510	344	245
Total Assets	3442	3240	2911	2681	2190	1636	1228	902	802	731	752	722	676	490	401

Delivery

#	Date	155 71% 264	Value (Cr)	Q/T 74	Del 36	Del 54
1	27-May	249	377	102	17	64
2	26-May	255	943	116	11	106
3	25-May	220	40	66	43	17
4	22-May	212	29	71	45	13
5	21-May	216	22	61	34	8
6	20-May	217	45	78	33	15
7	19-May	217	66	77	34	23
8	18-May	218	137	87	24	32
9	15-May	207	81	101	34	27
10	14-May	202	29	61	32	9
11	13-May	200	21	58	32	7
12	12-May	198	40	61	40	16
13	11-May	203	65	66	34	22
14	8-May	198	31	55	50	16
15	7-May	203	54	86	36	19
16	6-May	196	176	82	28	49
17	5-May	187	12	52	42	5
18	4-May	189	20	54	40	8
19	30-Apr	185	11	48	42	5
20	29-Apr	188	16	55	47	7
21	28-Apr	184	20	68	54	11
22	27-Apr	192	16	61	42	7
23	24-Apr	190	28	64	40	11
24	23-Apr	193	84	80	26	21
25	22-Apr	180	10	37	49	5
26	21-Apr	177	12	53	51	6
27	20-Apr	177	10	48	46	5
28	17-Apr	179	11	65	58	6
29	16-Apr	180	9	49	42	4
30	15-Apr	179	11	50	45	5
31	13-Apr	176	9	53	44	4
32	10-Apr	178	9	54	47	4
33	9-Apr	175	10	37	46	4
34	8-Apr	175	11	53	43	5
35	7-Apr	170	14	52	43	6
36	6-Apr	166	10	46	31	3
37	2-Apr	168	9	50	35	3
38	1-Apr	168	15	41	34	5
39	30-Mar	157	15	51	50	8
40	27-Mar	163	18	49	49	9
41	25-Mar	165	14	49	49	7
42	24-Mar	165	21	61	40	9
43	23-Mar	160	15	32	57	8
44	20-Mar	170	19	59	60	12

Daily Market Cap

Date	Total Market Cap	Change	Chg %
27-May	11,639c	1,664c	16.68
26-May	9,975c	17c	0.17
25-May	9,992c	253c	2.60
22-May	9,739c	21c	0.22
21-May	9,761c	100c	1.02
20-May	9,861c	69c	0.71
19-May	9,792c	120c	1.24
18-May	9,672c	205c	2.17
15-May	9,467c	270c	2.93
14-May	9,197c	197c	2.19
12-May	9,000c	282c	3.04
11-May	9,282c	78c	0.85
07-May	9,204c	184c	2.04
06-May	9,019c	455c	5.31
05-May	8,565c	44c	0.52
04-May	8,609c	257c	3.08
30-Apr	8,352c	168c	1.97
29-Apr	8,520c	107c	1.27
28-Apr	8,413c	115c	1.35
24-Apr	8,528c	213c	2.44
23-Apr	8,742c	630c	7.77
22-Apr	8,112c	75c	0.93
21-Apr	8,037c	106c	1.30
17-Apr	8,143c	67c	0.83
16-Apr	8,076c	15c	0.18
15-Apr	8,090c	0	0

Stock Checklist

Price is above from 52 week high low average: 76%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView